PGE1 vs ATP
The review found no eligible studies for this question.
- no estimate extractedStudies not reportedNo studies found
The review found no eligible studies for this question.
PGE1 may leads to lower total amputations compared with ATP (low certainty).
The review found no eligible studies for this question.
PGE1 may leads to higher adverse event (participants) compared with ATP (low certainty).
PGE1 showed no clear difference in ulcer healing (complete) compared with ATP (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
PGE1 showed no clear difference in adverse events (participants) compared with inositol niacinate (low certainty).
PGE1 showed no clear difference in rest‐pain relief compared with inositol niacinate (low certainty).
PGE1 showed no clear difference in ulcer healing compared with inositol niacinate (low certainty).
The review found no eligible studies for this question.
Iloprost showed no clear difference in total amputations compared with PGE1 (low certainty).
The review found no eligible studies for this question.
Iloprost probably leads to higher adverse events (participants) compared with PGE1 (moderate certainty).
Iloprost showed no clear difference in rest‐pain relief compared with PGE1 (low certainty).
Iloprost showed no clear difference in ulcer healing compared with PGE1 (low certainty).
The review found no eligible studies for this question.